Hims & Hers Health (NYSE:HIMS - Get Free Report) posted its quarterly earnings data on Monday. The company reported $0.32…
Hims & Hers stock maintains buy rating with TD Cowen after solid 3Q24…
Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Tuesday after the company reported strong third-quarter results and…
Hims & Hers Health exceeded revenue expectations, achieved substantial subscriber growth, and remains undervalued in the market. Learn more HIMS…
The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of…
The telehealth company will start offering a generic version of liraglutide in 2025 as consumers continue to struggle to secure…
Hims & Hers Health (NYSE:HIMS) Shares Gap Up on Strong Earnings…
In the third quarter, the brands eclipsed two million subscribers on its platform, with more than 1 million utilizing a…
Hims & Hers has released a white paper showing that 87% of its GLP-1 weight loss program customers are close…
Shares jump over 5% as Hims & Hers unveils plans for the first generic GLP-1--targeting Novos weight-loss dominance…
Hims & Hers both revenue channels witness strong revenue growth on the back of solid product demand in the third…
Hims & Hers Health raised its full-year sales guidance to $1.46 billion to $1.465 billion, up from a forecast in…
Seaport Research raised the firm’s price target on Hims Hers to $32 from $28 and keeps a Buy rating…
Canaccord Genuity Group lifted their target price on Hims & Hers Health from $24.00 to $28.00 and gave the company…
Operator: Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator…
These are the stocks posting the largest moves in premarket trading.…
Hims & Hers Health, Inc. hat im 3. Quartal 2024 beeindruckende Ergebnisse erzielt und die Erwartungen der Analysten deutlich übertroffen.…
Piper Sandler analyst Korinne Wolfmeyer raised the firm’s price target on Hims Hers to $21 from $18 and keeps…
Hims & Hers Health (NYSE:HIMS) is gearing up to launch an off-patent version of Novo Nordisks (NVO) (OTCPK:NONOF) older GLP-1…
Hims & Hers Health (HIMS) stock gains after its Q3 2024 results as company plans to launch a generic version…
Canaccord raised the firm’s price target on Hims Hers to $28 from $24 and keeps a Buy rating on…
Hims and Hers stock gets boost from BofA as marketing spend fuels user growth…
Earnings call: Hims & Hers reports robust Q3 growth, plans for expansion…
Earnings call: Hims & Hers reports robust Q3 growth, plans for expansion…
With a 77% revenue increase and a growing subscriber base, Hims & Hers Health Inc (HIMS) continues to innovate in…
Overview of the Recent Transaction On September 30, 2024, Vanguard Group Inc, a prominent investment firm, expanded its portfolio by…
With a 77% revenue increase and a growing subscriber base, Hims & Hers Health Inc (HIMS) continues to innovate in…
Hims & Hers Health, Inc. ( ($HIMS) ) has released its Q3 earnings. Here is a breakdown of the information…
Hims & Hers strong Q3 results and revenue growth demonstrate its robust business. Click here to see why HIMS stock…
…
…
Hims & Hers Health (HIMS) shares jumped in extended trading after the company reported better than expected third quarter revenue…
Hims & Hers both revenue channels witness strong revenue growth on the back of solid product demand in the third…
Shares of Hims & Hers Health Inc. rallied after hours on Monday after the wellness platform bumped its full-year sales…
Says trajectory in 2024 “nothing short of phenomenal.” Says business trajectory setting “robust foundation” for 2025. Comments taken from Q3…
Hims & Hers Health, Inc. (HIMS) came out with quarterly earnings of $0.06 per share, in line with the Zacks…
Hims & Hers Health (HIMS) delivered earnings and revenue surprises of 0% and 4.52%, respectively, for the quarter ended September…
Hims & Hers Health stock jumps 7% in after-hours trading after raising 2024 revenue guidance and beating Q3 financial results.…
Hims stock jumped late Monday after the online pharmacy beat expectations, helped by Hims & Hers weight-loss drug.…
Hims & Hers Health reported its third-quarter results after Mondays closing bell. Heres a look at the details from the…
Reports Q3 revenue $401.6M, consensus $382.2M. “Improving momentum in both the Hims and Hers brands delivered another strong quarter of…
Hims stock jumped late Monday after the online pharmacy beat expectations, helped by Hims & Hers weight-loss drug.…
Hims & Hers Health Q3 earnings beat estimates, raises guidance…
Hims & Hers Health Q3 earnings beat estimates, raises guidance…
Hims & Hers Health Q3 earnings beat estimates, raises guidance…
Hims Hers Health earnings beat by $0.22, revenue topped estimates…
Hims & Hers Health reports stunning 77% revenue surge to $401.6M in Q3, achieving profitability with $75.6M net income. See…
Hims & Hers Health will report third-quarter financial results after the market close on Monday. Analysts expect the company to…
Shares of Hims & Hers Health Inc (HIMS) surged 3.71% in mid-day trading on Nov 4. The stock reached an…
Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today…